Social, economic, and health impact of the respiratory syncytial virus: a systematic search (Q26852865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Eduardo G Pérez-Yarza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

José A. Melero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Manuel Sánchez Luna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

María Dolores Aguilar

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Antonio Javier Blasco

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Noelia Alfaro

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Pablo Lázaro

8

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

1 reference

30 October 2014

3 references

23 March 2019

1 July 2020

BMC Infectious Diseases

4 references

23 March 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 July 2020

14

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

544

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

7 June 2020

copyright license

2 references

23 March 2019

1 July 2020

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

The microbiology of asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Spectrum of respiratory viruses in children with community-acquired pneumonia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Determinants of asthma after severe respiratory syncytial virus bronchiolitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus infection in adult populations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998-2008

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Treatment of respiratory syncytial virus with palivizumab: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Meta‐analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Role of viral respiratory infections in asthma and asthma exacerbations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

The cost effectiveness of palivizumab: a systematic review of the evidence.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Cost effectiveness of palivizumab in Spain: an analysis using observational data.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

The burden of respiratory syncytial virus infection in young children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory viral infection in exacerbations of COPD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Diagnosis and management of bronchiolitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus infection in elderly and high-risk adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory viral infections in patients with chronic, obstructive pulmonary disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus infection in adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus infection in immunocompromised adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus and recurrent wheeze in healthy preterm infants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

[Study of variability in the management of acute bronchiolitis in Spain in relation to age of patients. National multicenter study (aBREVIADo project)].

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Recurrent wheezing in children with respiratory syncytial virus (RSV) bronchiolitis in Qatar

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Respiratory syncytial virus or influenza?

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Respiratory viruses and chronic rejection in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Community-acquired respiratory infections in young children with congenital heart diseases in the palivizumab era: the Spanish 4-season civic epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

What is the clinical relevance of respiratory syncytial virus bronchiolitis?: findings from a multi-center, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Risk of acute otitis media in relation to acute bronchiolitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

The Cost-Effectiveness of Palivizumab in the Prevention of Respiratory Syncytial Virus Bronchiolitis: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

The causal direction in the association between respiratory syncytial virus hospitalization and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Respiratory morbidity 20 years after RSV infection in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Impact of wheezing after respiratory syncytial virus infection on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0544-X

Mortality and morbidity of nosocomial respiratory syncytial virus (RSV) infection in ventilated children--a ten year perspective.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Acute Lower Respiratory Illness in Elderly Patients with Respiratory Syncytial Virus Infection

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219051

Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective

28 November 2018

1 reference

12 December 2020

Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Epidemiology of respiratory viruses in children admitted to an infant/toddler unit

1 reference

12 December 2020

Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

RSV hospitalisation and healthcare utilisation in moderately prematurely born infants

1 reference

12 December 2020

Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection

1 reference

12 December 2020

Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings

1 reference

12 December 2020

[The efficiency (cost-effectiveness) of palivizumab as prophylaxis against respiratory syncytial virus infection in premature infants with a gestational age of 32-35 weeks in Spain]

1 reference

12 December 2020

10.1186/S12879-014-0544-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 June 2020

1036266658

0 references

Fatcat ID

release_fyonla2qtzhenisj6od5avbyx4

0 references

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358423%20AND%20SRC:MED&resulttype=core&format=json